164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355
Articles > Article · 2022
Authors: D.W. Cescon, P. Schmid, H.S. Rugo, S-A. Im, M. Md Yusof, C.E. Gallardo, O. Lipatov, C.H. Barrios, J.M. Perez Garcia, H. Iwata, N. Masuda, M.A. Torregroza Otero, Erhan GÖKMEN, S. Loi, A. Haiderali, X. Zhou, Z. Guo, A. Martin Nguyen, J. Cortés
Annals of Oncology, International, WoS, 2022, vol 33, pp S197-S198